{
  "symbol": "KO",
  "year": 2024,
  "Period": "Q3",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": -0.2732,
    "outlook_sentiment": 0.2334,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.085
  },
  "top_positive": [
    {
      "sent": "8 NOTE\u00a04: INVESTMENTS Equity Securities The carrying values of our equity securities were included in the following line items in our consolidated balance sheets (in millions): Fair Value with Changes Recognized in Income Measurement Alternative \u2014 No Readily Determinable Fair Value March 29, 2024 Marketable securities $ 373 $ \u2014 Other investments 105 42 Other noncurrent assets 1,628 \u2014 Total equity securities $ 2,106 $ 42 December 31, 2023 Marketable securities $ 345 $ \u2014 Other investments 76 42 Other noncurrent assets 1,585 \u2014 Total equity securities $ 2,006 $ 42 The calculation of net unrealized gains and losses recognized during the period related to equity securities still held at the end of the period is as follows (in millions): Three Months Ended March 29, 2024 March 31, 2023 Net gains (losses) recognized during the period related to equity securities $ 183 $ 125 Less: Net gains (losses) recognized during the period related to equity securities sold during the period 49 1 Net unrealized gains (losses) recognized during the period related to equity securities still held at the end of the period $ 134 $ 124 Debt Securities Our debt securities consisted of the following (in millions): Gross Unrealized Estimated Fair Value Cost Gains Losses March 29, 2024 Trading securities $ 45 $ 1 $ ( 2 ) $ 44 Available-for-sale securities 1,516 29 ( 25 ) 1,520 Total debt securities $ 1,561 $ 30 $ ( 27 ) $ 1,564 December 31, 2023 Trading securities $ 43 $ \u2014 $ ( 2 ) $ 41 Available-for-sale securities 1,136 26 ( 28 ) 1,134 Total debt securities $ 1,179 $ 26 $ ( 30 ) $ 1,175 The carrying values of our debt securities were included in the following line items in our consolidated balance sheets (in millions): March 29, 2024 December 31, 2023 Trading Securities Available-for-Sale Securities Trading Securities Available-for-Sale Securities Marketable securities $ 44 $ 1,299 $ 41 $ 914 Other noncurrent assets \u2014 221 \u2014 220 Total debt securities $ 44 $ 1,520 $ 41 $ 1,134 9 The contractual maturities of these available-for-sale debt securities as of March\u00a029, 2024 were as follows (in millions): Cost Estimated Fair Value Within 1\u00a0year $ 224 $ 224 After 1\u00a0year through 5\u00a0years 1,075 1,080 After 5\u00a0years through 10\u00a0years 45 57 After 10\u00a0years 172 159 Total $ 1,516 $ 1,520 The Company expects that actual maturities may differ from the contractual maturities above because borrowers \nng commercial paper borrowings.",
      "score": 0.9949
    },
    {
      "sent": "8 NOTE\u00a04: INVESTMENTS Equity Securities The carrying values of our equity securities were included in the following line items in our consolidated balance sheets (in millions): Fair Value with Changes Recognized in Income Measurement Alternative \u2014 No Readily Determinable Fair Value March 29, 2024 Marketable securities $ 373 $ \u2014 Other investments 105 42 Other noncurrent assets 1,628 \u2014 Total equity securities $ 2,106 $ 42 December 31, 2023 Marketable securities $ 345 $ \u2014 Other investments 76 42 Other noncurrent assets 1,585 \u2014 Total equity securities $ 2,006 $ 42 The calculation of net unrealized gains and losses recognized during the period related to equity securities still held at the end of the period is as follows (in millions): Three Months Ended March 29, 2024 March 31, 2023 Net gains (losses) recognized during the period related to equity securities $ 183 $ 125 Less: Net gains (losses) recognized during the period related to equity securities sold during the period 49 1 Net unrealized gains (losses) recognized during the period related to equity securities still held at the end of the period $ 134 $ 124 Debt Securities Our debt securities consisted of the following (in millions): Gross Unrealized Estimated Fair Value Cost Gains Losses March 29, 2024 Trading securities $ 45 $ 1 $ ( 2 ) $ 44 Available-for-sale securities 1,516 29 ( 25 ) 1,520 Total debt securities $ 1,561 $ 30 $ ( 27 ) $ 1,564 December 31, 2023 Trading securities $ 43 $ \u2014 $ ( 2 ) $ 41 Available-for-sale securities 1,136 26 ( 28 ) 1,134 Total debt securities $ 1,179 $ 26 $ ( 30 ) $ 1,175 The carrying values of our debt securities were included in the following line items in our consolidated balance sheets (in millions): March 29, 2024 December 31, 2023 Trading Securities Available-for-Sale Securities Trading Securities Available-for-Sale Securities Marketable securities $ 44 $ 1,299 $ 41 $ 914 Other noncurrent assets \u2014 221 \u2014 220 Total debt securities $ 44 $ 1,520 $ 41 $ 1,134 9 The contractual maturities of these available-for-\npenses.",
      "score": 0.9942
    },
    {
      "sent": "Price, product and geographic mix was impacted by a variety of factors and events including, but not limited to, the following: \u2022 Europe, Middle East and Africa \u2014 favorable pricing initiatives, including inflationary pricing primarily in Nigeria, T\u00fcrkiye and Zimbabwe, and favorable geographic mix; \u2022 Latin America \u2014 favorable pricing initiatives, including inflationary pricing in Argentina, partially offset by unfavorable category mix; \u2022 North America \u2014 favorable pricing initiatives and favorable category mix, partially offset by unfavorable channel mix; \u2022 Asia Pacific \u2014 favorable pricing initiatives, as well as favorable category, package and geographic mix; \u2022 Global Ventures \u2014 unfavorable product mix, partially offset by favorable pricing initiatives; and \u2022 Bottling Investments \u2014 favorable pricing initiatives across most markets and favorable product and package mix, partially offset by unfavorable geographic mix.",
      "score": 0.9936
    }
  ],
  "top_negative": [
    {
      "sent": "The following tables provide a summary of cash, cash equivalents, restricted cash and restricted cash equivalents that constitute the total amounts shown in our consolidated statements of cash flows (in millions): March 29, 2024 December 31, 2023 Cash and cash equivalents $ 10,443 $ 9,366 Restricted cash and restricted cash equivalents 375 326 Cash, cash equivalents, restricted cash and restricted cash equivalents $ 10,818 $ 9,692 6 March 31, 2023 December 31, 2022 Cash and cash equivalents $ 12,004 $ 9,519 Restricted cash and restricted cash equivalents 276 306 Cash, cash equivalents, restricted cash and restricted cash equivalents $ 12,280 $ 9,825 Recently Issued Accounting Guidance In November 2023, the Financial Accounting Standards Board (\u201cFASB\u201d) issued Accounting Standards Update (\u201cASU\u201d) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses.",
      "score": -0.9612
    },
    {
      "sent": "4 THE COCA-COLA COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (In millions) Three Months Ended March 29, 2024 March 31, 2023 Operating Activities Consolidated net income $ 3,185 $ 3,113 Adjustments to reconcile consolidated net income to net cash provided by operating activities: Depreciation and amortization 262 286 Stock-based compensation expense 68 58 Deferred income taxes ( 173 ) 260 Equity (income) loss\u00a0\u2014 net of dividends ( 58 ) ( 249 ) Foreign currency adjustments 17 25 Significant (gains) losses\u00a0\u2014 net ( 1,401 ) ( 442 ) Other operating charges 1,532 88 Other items ( 59 ) ( 102 ) Net change in operating assets and liabilities ( 2,845 ) ( 2,877 ) Net Cash Provided by Operating Activities 528 160 Investing Activities Purchases of investments ( 2,552 ) ( 739 ) Proceeds from disposals of investments 444 815 Acquisitions of businesses, equity method investments and nonmarketable securities ( 8 ) ( 20 ) Proceeds from disposals of businesses, equity method investments and nonmarketable securities 2,893 319 Purchases of property, plant and equipment ( 370 ) ( 276 ) Proceeds from disposals of property, plant and equipment 14 21 Collateral (paid) received associated with hedging activities \u2014 net ( 105 ) 18 Other investing activities 14 ( 21 ) Net Cash Provided by (Used in) Investing Activities 330 117 Financing Activities Issuances of loans, notes payable and long-term debt 2,285 4,074 Payments of loans, notes payable and long-term debt ( 1,366 ) ( 1,174 ) Issuances of stock 290 229 Purchases of stock for treasury ( 702 ) ( 848 ) Dividends ( 99 ) ( 101 ) Other financing activities ( 2 ) ( 115 ) Net Cash Provided by (Used in) Financing Activities 406 2,065 Effect of Exchange Rate Changes on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ( 138 ) 113 Cash, Cash Equivalents, Restricted Cash and Res\n information on our assets held for sale and Note\u00a04 for additional information on our captive insurance companies.",
      "score": -0.8658
    },
    {
      "sent": "In general, we are self-insured for large portions of many different types of claims; however, we do use commercial insurance above our self-insured retentions to reduce the Company\u2019s risk of catastrophic loss.",
      "score": -0.765
    }
  ],
  "forward_snippets": [
    "All statements that address operating performance, events or developments that we expect or anticipate will occur in the future\u00a0\u2014 including statements relating to volume growth, share of sales and net income per share growth, and statements expressing general views about future operating results\u00a0\u2014 are forward-looking statements.",
    "The following tables provide a summary of cash, cash equivalents, restricted cash and restricted cash equivalents that constitute the total amounts shown in our consolidated statements of cash flows (in millions): March 29, 2024 December 31, 2023 Cash and cash equivalents $ 10,443 $ 9,366 Restricted cash and restricted cash equivalents 375 326 Cash, cash equivalents, restricted cash and restricted cash equivalents $ 10,818 $ 9,692 6 March 31, 2023 December 31, 2022 Cash and cash equivalents $ 12,004 $ 9,519 Restricted cash and restricted cash equivalents 276 306 Cash, cash equivalents, restricted cash and restricted cash equivalents $ 12,280 $ 9,825 Recently Issued Accounting Guidance In November 2023, the Financial Accounting Standards Board (\u201cFASB\u201d) issued Accounting Standards Update (\u201cASU\u201d) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses.",
    "The Company is currently evaluating the impact that ASU 2023-09 will have on our consolidated financial statements and whether we will apply the standard prospectively or retrospectively.",
    "8 NOTE\u00a04: INVESTMENTS Equity Securities The carrying values of our equity securities were included in the following line items in our consolidated balance sheets (in millions): Fair Value with Changes Recognized in Income Measurement Alternative \u2014 No Readily Determinable Fair Value March 29, 2024 Marketable securities $ 373 $ \u2014 Other investments 105 42 Other noncurrent assets 1,628 \u2014 Total equity securities $ 2,106 $ 42 December 31, 2023 Marketable securities $ 345 $ \u2014 Other investments 76 42 Other noncurrent assets 1,585 \u2014 Total equity securities $ 2,006 $ 42 The calculation of net unrealized gains and losses recognized during the period related to equity securities still held at the end of the period is as follows (in millions): Three Months Ended March 29, 2024 March 31, 2023 Net gains (losses) recognized during the period related to equity securities $ 183 $ 125 Less: Net gains (losses) recognized during the period related to equity securities sold during the period 49 1 Net unrealized gains (losses) recognized during the period related to equity securities still held at the end of the period $ 134 $ 124 Debt Securities Our debt securities consisted of the following (in millions): Gross Unrealized Estimated \nGuidance In November 2023, the Financial Accounting Standards Board (\u201cFASB\u201d) issued Accounting Standards Update (\u201cASU\u201d) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses.",
    "The Company is currently evaluating the impact that ASU 2023-09 will have on our consolidated financial statements and whether we will apply the standard prospectively or retrospectively."
  ],
  "curated_text": "Symbol: KO. Year: 2024. Period: Q3. ReportType: Q10. Section: Management Discussion and Analysis (MD&A). Key metrics include sentiment, forward outlook, and risk hedging.  Top positive sentences: 8 NOTE\u00a04: INVESTMENTS Equity Securities The carrying values of our equity securities were included in the following line items in our consolidated balance sheets (in millions): Fair Value with Changes Recognized in Income Measurement Alternative \u2014 No Readily Determinable Fair Value March 29, 2024 Marketable securities $ 373 $ \u2014 Other investments 105 42 Other noncurrent assets 1,628 \u2014 Total equity securities $ 2,106 $ 42 December 31, 2023 Marketable securities $ 345 $ \u2014 Other investments 76 42 Other noncurrent assets 1,585 \u2014 Total equity securities $ 2,006 $ 42 The calculation of net unrealized gains and losses recognized during the period related to equity securities still held at the end of the period is as follows (in millions): Three Months Ended March 29, 2024 March 31, 2023 Net gains (losses) recognized during the period related to equity securities $ 183 $ 125 Less: Net gains (losses) recognized during the period related to equity securities sold during the period 49 1 Net unrealized gains (losses) recognized during the period related to equity securities still held at the end of the period $ 134 $ 124 Debt Securities Our debt securities consisted of the following (in millions): Gross Unrealized Estimated Fair Value Cost Gains Losses March 29, 2024 Trading securities $ 45 $ 1 $ ( 2 ) $ 44 Available-for-sale securities 1,516 29 ( 25 ) 1,520 Total debt securities $ 1,561 $ 30 $ ( 27 ) $ 1,564 December 31, 2023 Trading securities $ 43 $ \u2014 $ ( 2 ) $ 41 Available-for-sale securities 1,136 26 ( 28 ) 1,134 Total debt securities $ 1,179 $ 26 $ ( 30 ) $ 1,175 The carrying values of our debt securities were included in the following line items in our consolidated balance sheets (in millions): March 29, 2024 December 31, 2023 Trading Securities Available-for-Sale Securities Trading Securities Available-for-Sale Securities Marketable securities $ 44 $ 1,299 $ 41 $ 914 Other noncurrent assets \u2014 221 \u2014 220 Total debt securities $ 44 $ 1,520 $ 41 $ 1,134 9 The contractual maturities of these available-for-sale debt securities as of March\u00a029, 2024 were as follows (in millions): Cost Estimated Fair Value Within 1\u00a0year $ 224 $ 224 After 1\u00a0year through 5\u00a0years 1,075 1,080 After 5\u00a0years through 10\u00a0years 45 57 After 10\u00a0years 172 159 Total $ 1,516 $ 1,520 The Company expects that actual maturities may differ from the contractual maturities above because borrowers \nng commercial paper borrowings. 8 NOTE\u00a04: INVESTMENTS Equity Securities The carrying values of our equity securities were included in the following line items in our consolidated balance sheets (in millions): Fair Value with Changes Recognized in Income Measurement Alternative \u2014 No Readily Determinable Fair Value March 29, 2024 Marketable securities $ 373 $ \u2014 Other investments 105 42 Other noncurrent assets 1,628 \u2014 Total equity securities $ 2,106 $ 42 December 31, 2023 Marketable securities $ 345 $ \u2014 Other investments 76 42 Other noncurrent assets 1,585 \u2014 Total equity securities $ 2,006 $ 42 The calculation of net unrealized gains and losses recognized during the period related to equity securities still held at the end of the period is as follows (in millions): Three Months Ended March 29, 2024 March 31, 2023 Net gains (losses) recognized during the period related to equity securities $ 183 $ 125 Less: Net gains (losses) recognized during the period related to equity securities sold during the period 49 1 Net unrealized gains (losses) recognized during the period related to equity securities still held at the end of the period $ 134 $ 124 Debt Securities Our debt securities consisted of the following (in millions): Gross Unrealized Estimated Fair Value Cost Gains Losses March 29, 2024 Trading securities $ 45 $ 1 $ ( 2 ) $ 44 Available-for-sale securities 1,516 29 ( 25 ) 1,520 Total debt securities $ 1,561 $ 30 $ ( 27 ) $ 1,564 December 31, 2023 Trading securities $ 43 $ \u2014 $ ( 2 ) $ 41 Available-for-sale securities 1,136 26 ( 28 ) 1,134 Total debt securities $ 1,179 $ 26 $ ( 30 ) $ 1,175 The carrying values of our debt securities were included in the following line items in our consolidated balance sheets (in millions): March 29, 2024 December 31, 2023 Trading Securities Available-for-Sale Securities Trading Securities Available-for-Sale Securities Marketable securities $ 44 $ 1,299 $ 41 $ 914 Other noncurrent assets \u2014 221 \u2014 220 Total debt securities $ 44 $ 1,520 $ 41 $ 1,134 9 The contractual maturities of these available-for-\npenses. Price, product and geographic mix was impacted by a variety of factors and events including, but not limited to, the following: \u2022 Europe, Middle East and Africa \u2014 favorable pricing initiatives, including inflationary pricing primarily in Nigeria, T\u00fcrkiye and Zimbabwe, and favorable geographic mix; \u2022 Latin America \u2014 favorable pricing initiatives, including inflationary pricing in Argentina, partially offset by unfavorable category mix; \u2022 North America \u2014 favorable pricing initiatives and favorable category mix, partially offset by unfavorable channel mix; \u2022 Asia Pacific \u2014 favorable pricing initiatives, as well as favorable category, package and geographic mix; \u2022 Global Ventures \u2014 unfavorable product mix, partially offset by favorable pricing initiatives; and \u2022 Bottling Investments \u2014 favorable pricing initiatives across most markets and favorable product and package mix, partially offset by unfavorable geographic mix. Top negative sentences: The following tables provide a summary of cash, cash equivalents, restricted cash and restricted cash equivalents that constitute the total amounts shown in our consolidated statements of cash flows (in millions): March 29, 2024 December 31, 2023 Cash and cash equivalents $ 10,443 $ 9,366 Restricted cash and restricted cash equivalents 375 326 Cash, cash equivalents, restricted cash and restricted cash equivalents $ 10,818 $ 9,692 6 March 31, 2023 December 31, 2022 Cash and cash equivalents $ 12,004 $ 9,519 Restricted cash and restricted cash equivalents 276 306 Cash, cash equivalents, restricted cash and restricted cash equivalents $ 12,280 $ 9,825 Recently Issued Accounting Guidance In November 2023, the Financial Accounting Standards Board (\u201cFASB\u201d) issued Accounting Standards Update (\u201cASU\u201d) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. 4 THE COCA-COLA COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (In millions) Three Months Ended March 29, 2024 March 31, 2023 Operating Activities Consolidated net income $ 3,185 $ 3,113 Adjustments to reconcile consolidated net income to net cash provided by operating activities: Depreciation and amortization 262 286 Stock-based compensation expense 68 58 Deferred income taxes ( 173 ) 260 Equity (income) loss\u00a0\u2014 net of dividends ( 58 ) ( 249 ) Foreign currency adjustments 17 25 Significant (gains) losses\u00a0\u2014 net ( 1,401 ) ( 442 ) Other operating charges 1,532 88 Other items ( 59 ) ( 102 ) Net change in operating assets and liabilities ( 2,845 ) ( 2,877 ) Net Cash Provided by Operating Activities 528 160 Investing Activities Purchases of investments ( 2,552 ) ( 739 ) Proceeds from disposals of investments 444 815 Acquisitions of businesses, equity method investments and nonmarketable securities ( 8 ) ( 20 ) Proceeds from disposals of businesses, equity method investments and nonmarketable securities 2,893 319 Purchases of property, plant and equipment ( 370 ) ( 276 ) Proceeds from disposals of property, plant and equipment 14 21 Collateral (paid) received associated with hedging activities \u2014 net ( 105 ) 18 Other investing activities 14 ( 21 ) Net Cash Provided by (Used in) Investing Activities 330 117 Financing Activities Issuances of loans, notes payable and long-term debt 2,285 4,074 Payments of loans, notes payable and long-term debt ( 1,366 ) ( 1,174 ) Issuances of stock 290 229 Purchases of stock for treasury ( 702 ) ( 848 ) Dividends ( 99 ) ( 101 ) Other financing activities ( 2 ) ( 115 ) Net Cash Provided by (Used in) Financing Activities 406 2,065 Effect of Exchange Rate Changes on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ( 138 ) 113 Cash, Cash Equivalents, Restricted Cash and Res\n information on our assets held for sale and Note\u00a04 for additional information on our captive insurance companies. In general, we are self-insured for large portions of many different types of claims; however, we do use commercial insurance above our self-insured retentions to reduce the Company\u2019s risk of catastrophic loss. Forward-looking snippets: All statements that address operating performance, events or developments that we expect or anticipate will occur in the future\u00a0\u2014 including statements relating to volume growth, share of sales and net income per share growth, and statements expressing general views about future operating results\u00a0\u2014 are forward-looking statements. The following tables provide a summary of cash, cash equivalents, restricted cash and restricted cash equivalents that constitute the total amounts shown in our consolidated statements of cash flows (in millions): March 29, 2024 December 31, 2023 Cash and cash equivalents $ 10,443 $ 9,366 Restricted cash and restricted cash equivalents 375 326 Cash, cash equivalents, restricted cash and restricted cash equivalents $ 10,818 $ 9,692 6 March 31, 2023 December 31, 2022 Cash and cash equivalents $ 12,004 $ 9,519 Restricted cash and restricted cash equivalents 276 306 Cash, cash equivalents, restricted cash and restricted cash equivalents $ 12,280 $ 9,825 Recently Issued Accounting Guidance In November 2023, the Financial Accounting Standards Board (\u201cFASB\u201d) issued Accounting Standards Update (\u201cASU\u201d) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. The Company is currently evaluating the impact that ASU 2023-09 will have on our consolidated financial statements and whether we will apply the standard prospectively or retrospectively. 8 NOTE\u00a04: INVESTMENTS Equity Securities The carrying values of our equity securities were included in the following line items in our consolidated balance sheets (in millions): Fair Value with Changes Recognized in Income Measurement Alternative \u2014 No Readily Determinable Fair Value March 29, 2024 Marketable securities $ 373 $ \u2014 Other investments 105 42 Other noncurrent assets 1,628 \u2014 Total equity securities $ 2,106 $ 42 December 31, 2023 Marketable securities $ 345 $ \u2014 Other investments 76 42 Other noncurrent assets 1,585 \u2014 Total equity securities $ 2,006 $ 42 The calculation of net unrealized gains and losses recognized during the period related to equity securities still held at the end of the period is as follows (in millions): Three Months Ended March 29, 2024 March 31, 2023 Net gains (losses) recognized during the period related to equity securities $ 183 $ 125 Less: Net gains (losses) recognized during the period related to equity securities sold during the period 49 1 Net unrealized gains (losses) recognized during the period related to equity securities still held at the end of the period $ 134 $ 124 Debt Securities Our debt securities consisted of the following (in millions): Gross Unrealized Estimated \nGuidance In November 2023, the Financial Accounting Standards Board (\u201cFASB\u201d) issued Accounting Standards Update (\u201cASU\u201d) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. The Company is currently evaluating the impact that ASU 2023-09 will have on our consolidated financial statements and whether we will apply the standard prospectively or retrospectively."
}